CHRONIC PAIN IN HEPATITIS PATIENTS PRE AND POST PEG-INTERFERON TREATMENT

被引：0
|
作者：
Lallemant, Camille [1 ]
Greenwood, Matthew [1 ]
Muir, Jane [2 ]
Keller, Majella [1 ]
Tibble, Jerry [1 ]
Whale, Richard [2 ]
Haq, Inam [2 ]
机构：
[1] Brighton & Sussex Univ Hosp, Brighton, E Sussex, England
[2] Brighton & Sussex Med Sch, Brighton, E Sussex, England
来源：
RHEUMATOLOGY | 2010年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I62 / I62
页数：1
相关论文
共 50 条
  • [1] Treatment with PEG-interferon and ribavirin therapy in dialysis patients with chronic hepatitis C
    Tan, Adriaan C.
    de Vries, Richard A.
    Adang, Rob
    Konings, Stijn
    Cnossen, Nynke
    Schalm, Solko W.
    van Leusen, Rob
    HEPATOLOGY, 2006, 44 (04) : 321A - 321A
  • [2] The effect of statins on PEG-interferon/ribavirin treatment for chronic hepatitis C
    Yen, Roy D.
    Prabhu, Anoop
    Mahl, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S217 - S217
  • [3] Peg-Interferon in Acute and Chronic Hepatitis C: A Review
    Palumbo, Emilio
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (06) : 573 - 578
  • [4] Treatment of chronic hepatitis delta with PEG-interferon alpha-2b.
    Castelnau, C
    Gordien, E
    Boyer, N
    Martinot, M
    Deny, P
    Marcellin, P
    HEPATOLOGY, 2004, 40 (04) : 675A - 675A
  • [5] Cytokine levels in peripheral blood of chronic hepatitis C (CHC) patients pre- and post treatment with peg-interferon alfa-2b and ribavirin
    Kaligeros, K
    Arseniou, V
    Tsakalia, L
    Demonakou, M
    Lagoudakis, M
    Agioutantis, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 148 - 148
  • [6] Peg-interferon lambda Treatment induces robust innate and adaptive immunity in chronic hepatitis B Patients
    Phillips, Sandra
    Mistry, Sameer
    Riva, Antonio
    Cooksley, Helen
    Hadzhiolova-Lebeau, Tanya
    Plavova, Slava
    Katzarov, Krum
    Simonova, Marieta
    Zeuzem, Stephan
    Woffendin, Clive
    Chen, Pei-Jer
    Peng, Cheng-Yuan
    Chang, Ting-Tsung
    Lueth, Stefan
    De Knegt, Robert
    Choi, Moon-Seok
    Wedemeyer, Heiner
    Dao, Michael
    Kim, Chang-Wook
    Chu, Heng-Chen
    Wind-Rotolo, Megan
    Williams, Roger
    Cooney, Elizabeth
    Chokshi, Shilpa
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [7] Salivary glands impairment in patients with chronic hepatitis C undergoing PEG-Interferon/ribavirin treatment.
    Aghemo, AM
    Rumi, MG
    Cuccarini, V
    Paglia, M
    Ottaviani, F
    Del Ninno, E
    Colombo, M
    HEPATOLOGY, 2003, 38 (04) : 625A - 625A
  • [8] Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C
    Taliani, G
    Biliotti, E
    Capanni, M
    Tozzi, A
    Bresci, S
    Pimpinelli, N
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 212 - 214
  • [9] Treatment with PEG-interferon and Ribavirin for Chronic Hepatitis C Increases Neutrophil and Monocyte Chemotaxis
    Giorgini, Alessia
    Capsoni, Franco
    Podda, Mauro
    Lleo, Ana
    Battezzati, Pier Maria
    Ongari, Anna Maria
    Selmi, Carlo
    Benetti, Alberto
    Malinverno, Federica
    Rossaro, Lorenzo
    Gershwin, M. Eric
    Zuin, Massimo
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 847 - 857
  • [10] COULD PEG-INTERFERON AND RIBAVIRIN BE EFFECTIVE AND SAFE IN THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C?
    Madonia, S.
    Barone, R.
    Pantalone, G. Restivo
    Sinagra, E.
    Perricone, G.
    Renda, M. C.
    Piazza, A.
    Maggio, A.
    Cottone, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S351 - S352
12345